• Predicting Compound Mechanism of Action Across Cell Lines Us

  2026-08-03

  Warchal et al. evaluated how machine learning classifiers can predict the mechanism of action (MoA) of compounds, such as Simvastatin, when applied to morphologically and genetically distinct cell lines using high-content imaging data. Their work highlights both the promise and current limitations of transferring ML-driven phenotypic profiling across diverse cellular contexts, informing experimental strategies for drug discovery and functional genomics.

• WM-8014: High-Precision KAT6A Inhibitor for Epigenetic Resea

  2026-08-03

  WM-8014 enables researchers to dissect selective histone acetyltransferase inhibition, allowing robust oncogene-induced senescence and cell cycle arrest assays without generalized cytotoxicity. Its nanomolar potency and reversible competitive mechanism make it a leading choice for advanced cancer biology and epigenetic workflows.

• Tacalcitol Monohydrate: Mechanistic Insights and Oncology Pr

  2026-08-02

  Explore Tacalcitol monohydrate, a synthetic analog of vitamin D3, through a deep dive into its molecular mechanisms and practical usage in cancer and dermatology research. This article uniquely dissects recent mechanistic breakthroughs and protocol strategies for advanced assay development.

• Carvedilol Phosphate in Hepatic Ischemia–Reperfusion Researc

  2026-08-01

  Carvedilol Phosphate, a high-purity non-selective beta blocker, is advancing hepatic ischemia–reperfusion injury (IRI) models by enabling robust modulation of adrenergic signaling. This article details stepwise experimental workflows, protocol optimizations, and troubleshooting approaches that leverage APExBIO’s Carvedilol Phosphate for reproducible outcomes in cardiovascular pharmacology research.

• Remdesivir (GS-5734): Optimizing Antiviral Workflows for RNA

  2026-07-31

  Remdesivir (GS-5734) is a benchmark tool for translational coronavirus and Ebola antiviral research, offering robust inhibition of RNA viruses in both cellular and animal models. This guide delivers actionable protocol enhancements, troubleshooting strategies, and a practical bridge from reference breakthroughs to daily virology lab success.

• Quercetin Suppresses Ferroptosis in Wilson’s Disease Liver I

  2026-07-31

  This study demonstrates that quercetin alleviates liver injury in Wilson’s disease models by directly inhibiting ferroptosis through the ACSL4/LPCAT3/ALOX15 pathway. The findings highlight a mechanistic advance for using quercetin as a multi-target modulator of iron homeostasis, lipid peroxidation, and mitochondrial function in metal-induced hepatic disorders.

• Dinaciclib (SCH727965): Advancing Tissue Boundary Research i

  2026-07-30

  Explore how Dinaciclib (SCH727965), a potent multi-CDK inhibitor, bridges mechanistic insights from developmental biology to translational oncology by enabling precise dissection of cell cycle and tissue boundary dynamics. This article synthesizes recent discoveries in Drosophila boundary formation with actionable guidance for cancer research, highlighting strategic applications and protocol considerations for translational investigators.

• Mc-Val-Cit-PABC-PNP: Protocol and Workflow Guidance for ADCs

  2026-07-30

  Mc-Val-Cit-PABC-PNP is a cathepsin B-cleavable ADC peptide linker designed for organic solvent-based antibody-drug conjugate synthesis, enabling selective lysosomal payload release in targeted drug delivery research. It is not suitable for aqueous workflows, diagnostic, or clinical applications, requiring strict adherence to solubility and storage protocols.

• Nanoparticle Uptake in Corneal Cells: Size, Surface, and Mec

  2026-07-29

  This study by Azadi and David systematically dissects how nanoparticle size and surface chemistry govern their uptake by human corneal epithelial cells. Detailed mechanistic insights into endocytic pathways provide a foundation for rational design of advanced ocular drug delivery systems.

• Rapid, Accessible Microfabrication: 3D Printing Meets Photol

  2026-07-29

  This study introduces a novel, cost-effective microfabrication workflow for biological laboratories by combining consumer 3D printing and digital maskless photolithography with standard fluorescence microscopes. The approach enables rapid, micrometer-resolution prototyping without clean room access, facilitating diverse applications from cytoskeletal studies to microfluidic device fabrication.

• Sulforaphane: From Mechanistic Insight to Translational Inno

  2026-07-28

  This thought-leadership article explores Sulforaphane (1-isothiocyanato-4-(methylsulfinyl)-butane) as a mechanistically validated modulator of oxidative stress and inflammasome signaling, focusing on translational strategies for cancer chemoprevention and inflammatory disease research. Drawing from recent evidence, including the inhibition of NLRP3 inflammasome activation in ulcerative colitis models, it offers practical guidance for experimental design, contextualizes APExBIO's Sulforaphane as a research tool, and charts a course for researchers seeking to bridge fundamental molecular mechanisms with preclinical and clinical applications.

• Advancing In Vitro Evaluation of Cancer Drug Responses

  2026-07-28

  Schwartz's dissertation introduces refined in vitro methods distinguishing between drug-induced growth inhibition and cell death, addressing critical limitations in preclinical oncology research. These insights enable more precise assessment of antiproliferative agents, such as PD 0332991, and inform protocol optimization for translational studies.

• Dinaciclib (SCH727965): Precision Tools for Cell Cycle and B

  2026-07-27

  Dinaciclib (SCH727965) is a multi-CDK inhibitor uniquely suited for dissecting cell cycle arrest and apoptosis induction in cancer and developmental models. This guide empowers researchers with practical protocols, troubleshooting advice, and cross-domain insights for leveraging Dinaciclib in studies of tissue boundary refinement and cancer cell compartmentalization.

• Optimizing Mouse IgG Detection with Cy3 Goat Anti-Mouse IgG

  2026-07-27

  The Cy3 Goat Anti-Mouse IgG (H+L) Antibody empowers researchers with precise, high-sensitivity detection in immunofluorescence, flow cytometry, and Western blotting. Learn how to maximize workflow reproducibility and signal amplification in biomarker studies, including translational applications in diabetic nephropathy.

• IPA-3 for Selective Pak1 Inhibition: Protocols & Advanced Us

  2026-07-26

  IPA-3 (1-[(2-hydroxynaphthalen-1-yl)disulfanyl]naphthalen-2-ol) uniquely enables precise, non-ATP-competitive Pak1 inhibition, facilitating high-fidelity kinase assays and translational models in cancer, neuroinflammation, and cell motility research. This guide delivers stepwise workflows, troubleshooting strategies, and deep-dives into how IPA-3 translates cutting-edge findings—such as nuclear pore regulation in HIV-1 infection—into actionable experimental design.

16059 records 1/1071 page Next 12345 下5页 Last page